ArticleBMJ (Clinical research ed.)1995
Increasing prescription of drugs for secondary prevention after myocardial infarction.
Article in BMJ (Clinical research ed.), 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.
- beta Blockade after myocardial infarction: systematic review and meta regression analysis.BMJ (Clinical research ed.) · 1999Pooled it
- Beta-blockers provide a differential survival benefit in patients with coronary artery disease undergoing contemporary post-percutaneous coronary intervention management.Scientific reports · 2020Article
- Use of evidence-based therapies after discharge among elderly patients with acute myocardial infarction.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2008Article
- Factors affecting over-the-counter use of aspirin in the secondary prophylaxis of cardiovascular disease.The British journal of general practice : the journal of the Royal College of General Practitioners · 2001Article
- [Economic analysis of secondary prevention of coronary heart disease with simvastatin (Zocor) in Germany].Medizinische Klinik (Munich, Germany : 1983) · 1997Review
- Is aspirin underused in myocardial infarction?PharmacoEconomics · 1997Review
- The one-stop coronary cholesterol clinic: a multidisciplinary approach to implementing evidence-based treatment.Postgraduate medical journal · 1996Article
- Increasing prescription of drugs for secondary prevention of myocardial infarction. Authors' recommendations are too restrictive.BMJ (Clinical research ed.) · 1996Article
- Increasing prescription of drugs for secondary prevention of myocardial infarction. Lipid lowering drugs should be considered too.BMJ (Clinical research ed.) · 1996Article
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.